Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10155869 | 0.88 | POLB (0.40) | EPHX1KMT2AACACBCYP3A4CYP2C19 | |
| SCHEMBL19703528 | 0.83 | EPHX1 (0.36) | EPHX1ACACBIRAK4 | |
| SCHEMBL5375866 | 0.82 | EPHX1 (0.41) | EPHX1KMT2AACACBPOLBAPEX1 | |
| SCHEMBL25885842 | 0.79 | EPHX1 (0.39) | EPHX1ACACBIRAK4 | |
| SCHEMBL14035271 | 0.79 | EPHX1 (0.31) | EPHX1ACACB | |
| SCHEMBL12987206 | 0.75 | EPHX1 (0.46) | EPHX1ALDH1A1ACACBIRAK4 | |
| SCHEMBL5365449 | 0.75 | ALDH1A1 (0.40) | EPHX1ALDH1A1POLB | |
| SCHEMBL13896533 | 0.74 | EPHX1 (0.41) | EPHX1SMN1; SMN2ACACBIRAK4 | |
| SCHEMBL3463291 | 0.74 | EPHX1 (0.41) | EPHX1ALDH1A1ACACBCYP2C19 | |
| SCHEMBL5369277 | 0.74 | PRKCA (0.40) | EPHX1ACACBIRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1712551-B1 | 3-Methyl oxetanemethanol derivatives and their use in perfume compositions | INT FLAVORS & FRAGRANCES INC (US) | 2012-11-21 | — | — | EP | disclosed |
| US-20070265180-A1 | 3-Methyl Oxetanemethanol Derivatives and Their Use in Perfume Compositions | INTERNATION FLAVORS & FRAGRANCES INC. | 2007-11-15 | — | — | US | disclosed |
| US-7265231-B2 | 3-methyl oxetanemethanol derivatives and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2007-09-04 | — | — | US | disclosed |
| US-20060234882-A1 | 3-Methyl oxetanemethanol derivatives and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2006-10-19 | — | — | US | disclosed |
| EP-1712551-A1 | 3-Methyl oxetanemethanol derivatives and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 2006-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265180-A1 | 3-Methyl Oxetanemethanol Derivatives and Their Use in Perfume Compositions | PNMT, CYP51A1, MSMO1 | EPHX1 95/4885SMN1; SMN2 4745/4885KMT2A 569/4885 |
| US-20060234882-A1 | 3-Methyl oxetanemethanol derivatives and their use in perfume compositions | PNMT, CYP51A1, MSMO1 | EPHX1 95/4885SMN1; SMN2 4745/4885KMT2A 569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.